Class of 2022
Boston—The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH), ALS Finding a Cure® and FightMND selected three recipients for their global two-year ALS Scholars in Therapeutics program. The program received an outstanding pool of global applications from 4 countries. This year’s selected recipients listed alphabetically are Dylan Galloway, PhD of the Washington University School of Medicine, Jacob Mann, PhD of Northwestern University Feinberg School of Medicine, and Roberta Piovesana, PhD of the University of Montreal.
The ALS Scholars in Therapeutics program provides funding for young investigators researching new treatments for people living with ALS. This two-year program is designed to engage physician-scientists and post-doctoral fellows to gain training and experience in therapy development for ALS at their home institution with a unique optional industry experience in year two. All ALS scholars will be part of the broader Healey & AMG Center, ALS Finding a Cure® and FightMND’s global community. By engaging motivated and creative individuals with a passion for bringing treatments to people living with ALS, we are expanding the community of experts and expediting therapy development.
Learn more about the ALS Scholars Program.